| Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes R Malik, G Chauhan, M Traylor, M Sargurupremraj, Y Okada, A Mishra, ... Nature genetics 50 (4), 524-537, 2018 | 1465 | 2018 |
| A common haplotype lowers PU. 1 expression in myeloid cells and delays onset of Alzheimer's disease K Huang, E Marcora, AA Pimenova, AF Di Narzo, M Kapoor, SC Jin, ... Nature neuroscience 20 (8), 1052-1061, 2017 | 380 | 2017 |
| An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations U Dube, JL Del-Aguila, Z Li, JP Budde, S Jiang, S Hsu, L Ibanez, ... Nature neuroscience 22 (11), 1903-1912, 2019 | 301 | 2019 |
| Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy AD Den Haan, BY Tan, MN Zikusoka, LI Lladó, R Jain, A Daly, C Tichnell, ... Circulation: Cardiovascular Genetics 2 (5), 428-435, 2009 | 261 | 2009 |
| The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk Y Deming, F Filipello, F Cignarella, C Cantoni, S Hsu, R Mikesell, Z Li, ... Science translational medicine 11 (505), eaau2291, 2019 | 254 | 2019 |
| Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders C Yang, FHG Farias, L Ibanez, A Suhy, B Sadler, MV Fernandez, F Wang, ... Nature neuroscience 24 (9), 1302-1312, 2021 | 187 | 2021 |
| A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain JL Del-Aguila, Z Li, U Dube, KA Mihindukulasuriya, JP Budde, ... Alzheimer's research & therapy 11, 1-16, 2019 | 177 | 2019 |
| Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms C Cruchaga, JL Del-Aguila, B Saef, K Black, MV Fernandez, J Budde, ... Alzheimer's & Dementia 14 (2), 205-214, 2018 | 141 | 2018 |
| HIV-associated neurocognitive disorders M Sanmarti, L Ibáñez, S Huertas, D Badenes, D Dalmau, M Slevin, ... Journal of molecular psychiatry 2, 1-10, 2014 | 126 | 2014 |
| TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers JL Del-Aguila, BA Benitez, Z Li, U Dube, KA Mihindukulasuriya, JP Budde, ... Molecular neurodegeneration 14, 1-13, 2019 | 88 | 2019 |
| Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease JJ Kim, D Vitale, DV Otani, MM Lian, K Heilbron, H Iwaki, J Lake, ... Nature genetics 56 (1), 27-36, 2024 | 85 | 2024 |
| Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease BA Benitez, AA Davis, SC Jin, L Ibanez, S Ortega-Cubero, P Pastor, ... Molecular neurodegeneration 11, 1-12, 2016 | 77 | 2016 |
| PATJ Low Frequency Variants Are Associated With Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis M Mola-Caminal, C Carrera, C Soriano-Tárraga, E Giralt-Steinhauer, ... Circulation research 124 (1), 114-120, 2019 | 75 | 2019 |
| Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels L Ibanez, U Dube, B Saef, J Budde, K Black, A Medvedeva, JL Del-Aguila, ... BMC neurology 17, 1-9, 2017 | 72 | 2017 |
| The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion Z Li, FHG Farias, U Dube, JL Del-Aguila, KA Mihindukulasuriya, ... Acta neuropathologica 139 (1), 45-61, 2020 | 67 | 2020 |
| Assessment of the genetic architecture of Alzheimer’s disease risk in rate of memory decline JL Del-Aguila, MV Fernández, S Schindler, L Ibanez, Y Deming, S Ma, ... Journal of Alzheimer’s Disease 62 (2), 745-756, 2018 | 67 | 2018 |
| Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing C Pou, M Noguera-Julian, S Pérez-Álvarez, F García, R Delgado, ... Clinical infectious diseases 59 (4), 578-588, 2014 | 56 | 2014 |
| Early neurological change after ischemic stroke is associated with 90-day outcome L Heitsch, L Ibanez, C Carrera, MM Binkley, D Strbian, T Tatlisumak, ... Stroke 52 (1), 132-141, 2021 | 51 | 2021 |
| A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments MJ Arranz, A Gonzalez-Rodriguez, J Perez-Blanco, R Penadés, ... Translational psychiatry 9 (1), 177, 2019 | 49 | 2019 |
| Clinical variables and genetic risk factors associated with the acute outcome of ischemic stroke: a systematic review NP Torres-Aguila, C Carrera, E Muiño, N Cullell, J Cárcel-Márquez, ... Journal of stroke 21 (3), 276, 2019 | 45 | 2019 |
